Teligent Pre-Tax Income 2010-2021 | TLGT
Teligent pre-tax income from 2010 to 2021. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Teligent Annual Pre-Tax Income
(Millions of US $) |
| 2020 |
$-120 |
| 2019 |
$-25 |
| 2018 |
$-36 |
| 2017 |
$-15 |
| 2016 |
$-12 |
| 2015 |
$7 |
| 2014 |
$5 |
| 2013 |
$-0 |
| 2012 |
$-4 |
| 2011 |
$-3 |
| 2010 |
$-4 |
| 2009 |
$-5 |
Teligent Quarterly Pre-Tax Income
(Millions of US $) |
| 2021-06-30 |
$-13 |
| 2021-03-31 |
$2 |
| 2020-12-31 |
$-78 |
| 2020-09-30 |
$-0 |
| 2020-06-30 |
$-14 |
| 2020-03-31 |
$-27 |
| 2019-12-31 |
$-5 |
| 2019-09-30 |
$-7 |
| 2019-06-30 |
$-4 |
| 2019-03-31 |
$-9 |
| 2018-12-31 |
$-14 |
| 2018-09-30 |
$-4 |
| 2018-06-30 |
$-13 |
| 2018-03-31 |
$-5 |
| 2017-12-31 |
$-6 |
| 2017-09-30 |
$-9 |
| 2017-06-30 |
$-1 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$-5 |
| 2016-09-30 |
$-3 |
| 2016-06-30 |
$-3 |
| 2016-03-31 |
$-1 |
| 2015-12-31 |
$-6 |
| 2015-09-30 |
$-3 |
| 2015-06-30 |
$9 |
| 2015-03-31 |
$7 |
| 2014-12-31 |
$6 |
| 2014-09-30 |
$-0 |
| 2014-06-30 |
$-0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$0 |
| 2013-09-30 |
$-0 |
| 2013-06-30 |
$-0 |
| 2013-03-31 |
$-0 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-1 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-0 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-1 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$-1 |
| 2009-06-30 |
$-2 |
| 2009-03-31 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
